CONCENTRIX CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.01 USD | -0.85% |
|
-0.33% | -43.99% |
| Mar. 28 | North American Morning Briefing : Stocks Set for -2- | DJ |
| Mar. 27 | BofA Securities Downgrades Concentrix to Underperform From Neutral | MT |
Valuation
| Fiscal Period: November | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 4,136 | 8,670 | 6,243 | 6,260 | 3,630 | - | - |
| Enterprise Value (EV) 1 | 4,136 | 8,670 | 6,243 | 10,907 | 8,499 | 7,754 | 6,905 |
| P/E ratio | 25.1 x | 21.6 x | 14.8 x | 16.5 x | 11.4 x | 8.1 x | - |
| Yield | - | 0.15% | 0.84% | - | 2.2% | 2.35% | 2.84% |
| Capitalization / Revenue | 0.88 x | 1.55 x | 0.99 x | 0.88 x | 0.38 x | 0.37 x | 0.35 x |
| EV / Revenue | 0.88 x | 1.55 x | 0.99 x | 1.53 x | 0.89 x | 0.78 x | 0.67 x |
| EV / EBITDA | 6.48 x | 9.92 x | 6.06 x | 9.23 x | 5.14 x | 4.42 x | 3.68 x |
| EV / FCF | - | - | - | 21.9 x | 12.8 x | 9 x | 6.63 x |
| FCF Yield | - | - | - | 4.56% | 7.81% | 11.1% | 15.1% |
| Price to Book | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 51,700 | 52,227 | 51,016 | 66,601 | 65,992 | - | - |
| Reference price 2 | 80.00 | 166.0 | 122.4 | 93.99 | 55.01 | 55.01 | 55.01 |
| Announcement Date | 1/11/21 | 1/18/22 | 1/19/23 | 1/24/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: November | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 4,720 | 5,587 | 6,324 | 7,115 | 9,598 | 9,936 | 10,358 |
| EBITDA 1 | 638.5 | 874 | 1,031 | 1,182 | 1,654 | 1,753 | 1,877 |
| EBIT 1 | 509.4 | 733.7 | 884.1 | 1,010 | 1,413 | 1,485 | - |
| Operating Margin | 10.79% | 13.13% | 13.98% | 14.2% | 14.72% | 14.95% | - |
| Earnings before Tax (EBT) 1 | - | 555.7 | 605 | 408.2 | 451.2 | 633.7 | 871.9 |
| Net income 1 | 164.8 | 399.9 | 428.5 | 307.9 | 319.9 | 446.2 | - |
| Net margin | 3.49% | 7.16% | 6.77% | 4.33% | 3.33% | 4.49% | - |
| EPS 2 | 3.190 | 7.700 | 8.280 | 5.700 | 4.827 | 6.790 | - |
| Free Cash Flow 1 | - | - | - | 497.5 | 664 | 862 | 1,041 |
| FCF margin | - | - | - | 6.99% | 6.92% | 8.68% | 10.05% |
| FCF Conversion (EBITDA) | - | - | - | 42.1% | 40.15% | 49.19% | 55.45% |
| FCF Conversion (Net income) | - | - | - | 161.59% | 207.57% | 193.2% | - |
| Dividend per Share 2 | - | 0.2500 | 1.025 | - | 1.210 | 1.290 | 1.560 |
| Announcement Date | 1/11/21 | 1/18/22 | 1/19/23 | 1/24/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: november | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,467 | 1,536 | 1,568 | 1,580 | 1,641 | 1,636 | 1,615 | 1,633 | 2,231 | 2,403 | 2,347 | 2,384 | 2,441 | 2,476 | 2,414 |
| EBITDA 1 | 238.2 | 237.9 | 249.9 | 258.4 | 284.8 | 255.8 | 258.8 | 269.3 | 397.9 | 384.3 | 389.4 | 435 | 458.5 | - | - |
| EBIT 1 | 203.4 | 201.9 | 212.8 | 221.5 | 248 | 217.6 | 220.6 | 231 | 340.8 | 319.1 | 324.7 | 371.1 | 394.6 | - | - |
| Operating Margin | 13.87% | 13.14% | 13.57% | 14.02% | 15.12% | 13.3% | 13.66% | 14.15% | 15.28% | 13.28% | 13.84% | 15.57% | 16.16% | - | - |
| Earnings before Tax (EBT) 1 | 154.9 | 146.6 | 146.5 | 149.4 | 162.6 | 118.3 | 106 | 106.8 | 77.11 | 72.82 | 79 | 138.3 | 161.1 | - | - |
| Net income 1 | 122.3 | 110.3 | 113.1 | 106.7 | 103.2 | 87.87 | 78.85 | 77.64 | 67.83 | 52.1 | 56.2 | 96.78 | 115.5 | - | - |
| Net margin | 8.34% | 7.18% | 7.22% | 6.75% | 6.29% | 5.37% | 4.88% | 4.75% | 3.04% | 2.17% | 2.39% | 4.06% | 4.73% | - | - |
| EPS 2 | 2.350 | 2.090 | 2.140 | 2.040 | 2.010 | 1.680 | 1.510 | 1.490 | 1.090 | 0.7600 | 0.8467 | 1.463 | 1.753 | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 1/18/22 | 3/29/22 | 6/27/22 | 9/28/22 | 1/19/23 | 3/29/23 | 6/28/23 | 9/27/23 | 1/24/24 | 3/26/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: november | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 4,647 | 4,869 | 4,124 | 3,275 |
| Net Cash position 1 | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | 3.932 x | 2.944 x | 2.353 x | 1.745 x |
| Free Cash Flow 1 | - | - | - | 497 | 664 | 862 | 1,041 |
| ROE (net income / shareholders' equity) | 16.8% | 21.4% | 22.9% | 18.1% | 18.7% | 17.7% | 19% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - |
| Cash Flow per Share 2 | 9.840 | 9.900 | 11.60 | 12.60 | 14.00 | 15.10 | - |
| Capex 1 | - | - | - | 181 | 290 | 301 | 308 |
| Capex / Sales | - | - | - | 2.54% | 3.02% | 3.03% | 2.98% |
| Announcement Date | 1/11/21 | 1/18/22 | 1/19/23 | 1/24/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
55.01
USD
Average target price
94.8
USD
Spread / Average Target
+72.33%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -43.99% | 3.63B | |
| +10.55% | 67.6B | |
| +11.64% | 18.21B | |
| +9.40% | 13.37B | |
| +16.53% | 9.94B | |
| -32.90% | 5.74B | |
| -10.98% | 5.57B | |
| -4.09% | 4.91B | |
| -4.83% | 4.87B | |
| 0.00% | 4.3B |
- Stock Market
- Equities
- CNXC Stock
- Financials Concentrix Corporation
